However, GSDMC and GSDMD had high homozygous amplification frequencies in ovarian serous cystadenocarcinoma (OV), oesophageal carcinoma (ESCA), uterine carcinosarcoma (UCS), breast invasive carcinoma (BRCA), stomach adenocarcinoma (STAD), liver hepatocellular carcinoma (LIHC), and uveal melanoma (UVM). This evidence concerns the gene GSDMC and gastric adenocarcinoma.